Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership523,711 shares
Latest Disclosed Value $ 15,559,454
Invesco Ltd. reports 10.47% increase in ownership of TVTX / Travere Therapeutics, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 523,711 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $15,559,454 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 474,075 shares of Travere Therapeutics, Inc.. This represents a change in shares of 10.47% during the quarter. The current value of the position is $23,671,737 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 523,711 49,636 10.47 15,559 -14.11 0.0024
2026-02-19 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 474,075 -153,827 -24.50 18,114 20.71 0.0028
2025-11-13 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 627,902 116,983 22.90 15,007 98.47 0.0024
2025-08-13 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 510,919 -55,008 -9.72 7,562 -25.44 0.0013
2025-05-12 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 565,927 -293,015 -34.11 10,141 -32.22 0.0019
2025-02-13 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 858,942 493,736 135.19 14,963 192.86 0.0028
2024-11-12 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 365,206 334,226 1,078.84 5,109 1,911.42 0.0010
2024-08-13 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 30,980 -2,207 -6.65 255 -0.39 0.0001
2024-05-14 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 33,187 -21,800 -39.65 256 -48.38 0.0001
2024-02-13 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 54,987 -758,265 -93.24 494 -93.20 0.0001
2023-11-13 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 813,252 113,250 16.18 7,270 -32.38 0.0020
2023-08-11 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 700,002 149,546 27.17 10,752 -13.14 0.0028
2023-05-12 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 550,456 -6,220 -1.12 12,380 5.75 0.0035
2023-02-13 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 556,676 119,090 27.22 11,707 8.56 0.0034
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 437,586 -61,900 -12.39 10,783 -10.91 0.0035
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 499,486 100,129 25.07 12,103 17.60 0.0037
2022-05-16 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 399,357 -111,844 -21.88 10,292 -35.14 0.0026
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 511,201 474,229 1,282.67 15,868 1,669.01 0.0038
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 36,972 2,868 8.41 897 80.48 0.0002
2021-08-17 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 34,104 -356,987 -91.28 497 -94.91 0.0001
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 391,091 360,928 1,196.59 9,765 1,087.96 0.0026
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 30,163 -475,762 -94.04 822 -91.20 0.0002
2020-11-16 2020-09-30 13F RETROPHIN COM 761299106 505,925 -116,177 -18.67 9,339 -26.45 0.0032
2020-08-14 2020-06-30 13F RETROPHIN COM 761299106 622,102 595,456 2,234.69 12,698 3,164.27 0.0045
2020-05-15 2020-03-31 13F RETROPHIN COM 761299106 26,646 9,349 54.05 389 58.13 0.0002
2020-02-14 2019-12-31 13F RETROPHIN COM 761299106 17,297 -1,104 -6.00 246 15.49 0.0001
2019-11-14 2019-09-30 13F RETROPHIN COM 761299106 18,401 -1,064,209 -98.30 213 -99.02 0.0001
2019-08-14 2019-06-30 13F/A-1 RETROPHIN COM 761299106 1,082,610 12,631 1.18 21,750 -10.17 0.0056
2019-08-14 2019-06-30 13F RETROPHIN COM 761299106 1,082,610 -243,503 21,750
2019-05-15 2019-03-31 13F RETROPHIN COM 761299106 1,069,979 10,663 1.01 24,213 1.01 0.0082
2019-02-14 2018-12-31 13F RETROPHIN COM 761299106 1,059,316 -517,525 -32.82 23,972 -47.08 0.0092
2018-11-14 2018-09-30 13F RETROPHIN COM 761299106 1,576,841 540,987 52.23 45,302 60.43 0.0143
2018-08-14 2018-06-30 13F RETROPHIN COM 761299106 1,035,854 -710,020 -40.67 28,237 -27.67 0.0093
2018-05-15 2018-03-31 13F RETROPHIN COM 761299106 1,745,874 689,291 65.24 39,038 75.36 0.0146
2018-02-14 2017-12-31 13F RETROPHIN COM 761299106 1,056,583 -111,578 -9.55 22,262 -23.44 0.0080
2017-11-14 2017-09-30 13F RETROPHIN COM 761299106 1,168,161 29,852 2.62 29,076 31.73 0.0107
2017-08-14 2017-06-30 13F RETROPHIN COM 761299106 1,138,309 28,064 2.53 22,072 7.69 0.0069
2017-05-15 2017-03-31 13F RETROPHIN COM 761299106 1,110,245 -3,470 -0.31 20,495 -2.79 0.0067
2017-02-14 2016-12-31 13F RETROPHIN COM 761299106 1,113,715 -16,149 -1.43 21,083 -16.62 0.0071
2016-11-14 2016-09-30 13F RETROPHIN COM 761299106 1,129,864 -40,219 -3.44 25,286 21.33 0.0087
2016-08-15 2016-06-30 13F RETROPHIN COM 761299106 1,170,083 406,257 53.19 20,840 99.73 0.0077
2016-05-16 2016-03-31 13F RETROPHIN COM 761299106 763,826 7,428 0.98 10,434 -28.49 0.0042
2016-02-16 2015-12-31 13F RETROPHIN COM 761299106 756,398 31,994 4.42 14,591 -0.58 0.0058
2015-11-16 2015-09-30 13F RETROPHIN COM 761299106 724,404 484,981 202.56 14,676 84.91 0.0062
2015-08-14 2015-06-30 13F RETROPHIN COMMON 761299106 239,423 169,707 243.43 7,937 375.27 0.0031
2015-05-15 2015-03-31 13F RETROPHIN COMMON 761299106 69,716 69,716 1,670 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.